Newsletter
Reimagining Compression Therapy for Lymphedema and Venous Disease with Andy Doraiswamy, Founder and CEO of Koya Medical

Outcomes Rocket

Reimagining Compression Therapy for Lymphedema and Venous Disease with Andy Doraiswamy, Founder and CEO of Koya Medical

October 6, 2021

Reimagining Compression Therapy for Lymphedema and Venous Disease with Andy Doraiswamy, Founder and CEO of Koya Medical

In this episode of Outcomes Rocket MedTech, we have the privilege of hosting Andy Doraiswamy, founder and CEO of Koya Medical and a finalist in Medtech Innovator in 2019. Koya is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases to increase movement mobility and personalized care that is unavailable with traditional compression therapy.

Andy discusses how his company’s reimagined treatment delivers improved quality of life for patients with movement and mobility problems. He talks about Dayspring’s advantage over existing solutions,  the recent 501k clearance from the FDA, and the new CMS code. He shares his thoughts on some important things an innovator needs like having the right backers, having a fantastic team who understands your mission, and being transparent with them. Get your notes ready because there’s plenty of things to learn from this interview with Andy. Please tune in!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Proudly supported by:

cover
COVID, AI, and the Future of Medicine with Eric Topol Exploring lingering questions about COVID-19 with Eric Topol, the Founder and Director of the Scripps Research Translational Institute.